Login
ENvue Medical Inc logo

ENvue Medical Inc

envuemed.com

ENvue Medical Inc (FEED) is a medical device company that is developing and seeking to commercialize medical device product candidates. The company was formerly known as NanoVibronix, Inc. and adopted its current name following a merger completed on February 14, 2025, in which it acquired ENvue Medical Holdings LLC. Revenue generation from commercial products had not been established as of the fiscal year ended December 31, 2024, and management disclosed substantial doubt about the company's ability to continue as a going concern in the 10-K filed April 15, 2026. The company depends on raising additional capital to fund clinical trials and product development, and expects to continue incurring losses. Third-party reimbursement from Medicare, Medicaid, and commercial insurers is identified as a key condition for any future commercially viable market for its products.

Products & Services

The company is developing medical device product candidates. Specific product names, indications, or development-stage details are not described in the available filing excerpts.

Revenue Model

The company had not demonstrated a commercial revenue model as of FY2024. Future revenue, if achieved, is expected to depend on product sales through direct or third-party distribution channels, with reimbursement from third-party payers including Medicare, Medicaid, and commercial insurers described as necessary for commercial viability.

Customers & Markets

The end market is healthcare, with patients and healthcare providers as the ultimate customers. Third-party payers including Medicare, Medicaid, and commercial insurers are identified as gatekeepers for product reimbursement. The company is subject to HIPAA and GDPR regulations, indicating potential handling of patient health information.

Geographic Exposure

The filing references U.S. federal healthcare regulations as primary compliance obligations, with additional references to EU GDPR and foreign data protection laws, suggesting at least anticipated international operations. Specific revenue by geography is not disclosed in the available excerpts.

Financial Snapshot

Revenue
TTM
$2.181M
Gross Margin
TTM
-26.98%
Net Income
TTM
-$20.91M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
90.27%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$32.02M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$12.41M

Stock Price

Loading...
Market Cap: $3.4388 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support